# Bupropion HCL ER

Canonical: https://abierto.us/opportunities/spe2d223d0002

- Solicitation number: SPE2D2-23-D-0002
- Notice type: Award notice
- Status: Awarded to RADHA PHARMACEUTICALS Inc. Hauppauge for $23,278,523.95
- Department: Department of Defense
- Agency: Defense Logistics Agency
- Contracting office: DLA Troop Support (SPE2D2)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- Place of performance: Hauppauge, New York
- First posted: September 14, 2026
- Last posted: September 14, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/885609e0a0a44507927f0fb893d641d5/view

## Description

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.

Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

## Publications

- September 14, 2026: Award notice. Notice 885609e0a0a44507927f0fb893d641d5. https://sam.gov/workspace/contract/opp/885609e0a0a44507927f0fb893d641d5/view

## Points of contact

- Kyle Lewicki, kyle.lewicki@dla.mil, 4457370977
- Jason Wray, jason.wray@dla.mil, 4457376304

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/spe2d223d0002.